The Sciences
Health
Environment
Aerospace
Education
Facebook
Twitter
The Sciences
Health
Environment
Aerospace
Education
The Sciences
Health
Environment
Aerospace
Education
cytokine storm
Rogue Antibodies Help Explain Long COVID-19
How ICMR and Others Spun Covaxin’s Phase 1 Trial Results Out of Context
Four Months After Itolizumab ‘Trial’ and 9 Million Infections Later – No Progress
How Does COVID-19 Damage Our Lungs?
Nine Months, 28M Cases: How COVID-19’s Clinical Landscape Has Changed
Review: Why Are Blood Clots Such a Major Problem in Severe COVID-19?
Itolizumab for COVID-19: Who Benefits When the Drug Regulator Is Opaque?
Posts navigation
1
2
3
Scroll To Top